CD36-driven FAO enhances tumor cell survival in stress-induced environments by providing an alternative energy source, reducing reactive oxygen species (ROS)-mediated cell death, and maintaining cancer stem cell (CSC) populations, contributing to chemotherapy, radiotherapy, and immunotherapy resistance [35–37]. This evidence concerns the gene CD36 and neoplasm.